Rational Design of Reversible Acetylcholinesterase Inhibitors

被引:29
作者
Barril, X. [1 ]
Kalko, S. G. [1 ]
Orozco, M. [2 ]
Luque, F. J. [1 ]
机构
[1] Univ Barcelona, Fac Farm, Dept Quim Fis, E-08028 Barcelona, Spain
[2] Univ Barcelona, Fac Quim, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain
关键词
D O I
10.2174/1389557023406494
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A large amount of structural information on AChE and AChE-inhibitor complexes is currently available. Based on that, molecular modeling studies can be intensively used to gain insight into the mechanism of action of the enzyme and the molecular determinants that modulate the potency of inhibitors. In turn, this knowledge can be exploited to design new compounds leading to more effective cholinergic strategies. This manuscript reviews recent developments in the design of reversible acetylcholinesterase inhibitors.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 109 条
[1]   Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils [J].
Alvarez, A ;
Opazo, C ;
Alarcon, R ;
Garrido, J ;
Inestrosa, NC .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (03) :348-361
[2]  
[Anonymous], 1987, DRUGS FUTURE, V12, P1032
[3]  
[Anonymous], LANCET
[4]   The determinants of pK(a)s in proteins [J].
Antosiewicz, J ;
McCammon, JA ;
Gilson, MK .
BIOCHEMISTRY, 1996, 35 (24) :7819-7833
[5]  
Antosiewicz J, 1996, J COMPUT CHEM, V17, P1633, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1633::AID-JCC5>3.0.CO
[6]  
2-M
[7]  
Antosiewicz J, 1996, BIOPOLYMERS, V39, P85, DOI 10.1002/(SICI)1097-0282(199607)39:1<85::AID-BIP9>3.3.CO
[8]  
2-K
[9]  
ASHANI Y, 1994, MOL PHARMACOL, V45, P555
[10]  
Bacou F., 1991, CHOLINESTERASES STRU